Cancer of the larynx

Lisa Licitra, Jacques Bernier, Cesare Grandi, Laura Locati, Marco Merlano, Gemma Gatta, Jean Louis Lefebvre

Research output: Contribution to journalArticlepeer-review


In Europe, laryngeal cancer accounts for only 2-5% of all cancers, the incidence being much higher among males than among females. Smoke and alcohol represent the major behavioural risk factors. Several carcinogens, occupations and vitamin deficiencies have been associated with laryngeal cancer. A genetic susceptibility to environmental risk factors and carcinogens is recognized. Hoarseness is the main symptom for which patients call for medical consultation. Mucosa is the most common histologic site of the primary lesions considered in the present chapter. Nodal involvement, the site and volume of the primary tumour, and some genes expression represent the major prognostic factors. A high death rate for not cancer-related events is to be pointed out. The loco-regional extent of the disease determines the success of cure. Surgery and radiotherapy represent the main therapeutic options. The choice between these two procedures is often controversial.

Original languageEnglish
Pages (from-to)65-80
Number of pages16
JournalCritical Reviews in Oncology/Hematology
Issue number1
Publication statusPublished - Jul 1 2003


  • Chemotherapy
  • Evidence-based treatment
  • Larynx
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Cancer of the larynx'. Together they form a unique fingerprint.

Cite this